Current issue
Journal content
Articles in press
Archive
About the Journal
About the Polish Annals of Medicine
Editorial Board
Abstracting & indexing
Open Access policy
Charges
Affiliated institutions
Contact
Instructions
Peer review process
Guide for authors
Publication ethics
Ethics and Patient Consent
User License
Usage of third party materials
Disclaimer
Statement on Artificial Intelligence
Reviewers
Guide for reviewers
Review Form
RESEARCH PAPER
Current international experience in drafting and implementing safety measures in vaccination delivery
1
Department of Surgical Dentistry and Pediatric Surgical Dentistry, Osh State University, Kyrgyz Republic
2
Department of Clinical Subjects and General Nursing, Nursing in Internal Disease, Pediatrics, University of Medicine, Tirana, Albania
3
Department of Morphological Disciplines, S. Tentishev Asian Medical Institute, Kant, Kyrgyz Republic
4
Department of Propedeutics of Internal Diseases, Medical University of Plovdiv, Bulgaria
Submission date: 2024-11-22
Final revision date: 2025-01-09
Acceptance date: 2025-01-10
Online publication date: 2025-08-27
Corresponding author
Abdyrakman Eshiev
Department of Surgical Dentistry and Pediatric Surgical Dentistry, Osh State University, Osh 723500, Kyrgyz Republic.
Department of Surgical Dentistry and Pediatric Surgical Dentistry, Osh State University, Osh 723500, Kyrgyz Republic.
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Vaccination remains a cornerstone in combating infectious diseases, and understanding the global strategies and disparities in vaccination delivery is critical for improving public health outcomes.
Aim:
This study focused on analysing the approaches and best practices of global health organisations in designing and implementing safe vaccination of the population to prevent infectious diseases, reduce their prevalence, and minimize associated adverse events.
Material and methods:
The scientific work was based on a comparison of official data on vaccination against Covid-19 in the USA, Bulgaria, Italy, and Europe.
Results and discussion:
By the end of 2021, Italy and the USA achieved high vaccination rates, with over 80% of Italy’s population and 65% of the US population receiving at least one dose. In contrast, Bulgaria, Romania, and Croatia had significantly lower rates, with revaccination coverage averaging below 25%. Strategies for combating diseases like polio, measles, and yellow fever were also found to be effective and safe, despite regional disparities in implementation.
Conclusions:
The study highlights substantial disparities in vaccination rates between countries, emphasizing the need for targeted interventions in regions with low coverage. While international health organizations have ensured the safety and effectiveness of vaccination strategies, addressing these gaps is essential for improving global health equity and reducing the burden of infectious diseases.
Vaccination remains a cornerstone in combating infectious diseases, and understanding the global strategies and disparities in vaccination delivery is critical for improving public health outcomes.
Aim:
This study focused on analysing the approaches and best practices of global health organisations in designing and implementing safe vaccination of the population to prevent infectious diseases, reduce their prevalence, and minimize associated adverse events.
Material and methods:
The scientific work was based on a comparison of official data on vaccination against Covid-19 in the USA, Bulgaria, Italy, and Europe.
Results and discussion:
By the end of 2021, Italy and the USA achieved high vaccination rates, with over 80% of Italy’s population and 65% of the US population receiving at least one dose. In contrast, Bulgaria, Romania, and Croatia had significantly lower rates, with revaccination coverage averaging below 25%. Strategies for combating diseases like polio, measles, and yellow fever were also found to be effective and safe, despite regional disparities in implementation.
Conclusions:
The study highlights substantial disparities in vaccination rates between countries, emphasizing the need for targeted interventions in regions with low coverage. While international health organizations have ensured the safety and effectiveness of vaccination strategies, addressing these gaps is essential for improving global health equity and reducing the burden of infectious diseases.
FUNDING
None declared.
CONFLICT OF INTEREST
None declared.
REFERENCES (45)
1.
UNDP. Global Dashboard for Vaccine Equity Data Futures Exchange. 2021. https://data.undp.org/insights.... Accessed: January 5, 2025.
2.
Ioannidis JPA, Pezzullo AM, Cristiano A, Boccia S. Global estimates of lives and life-years saved by COVID-19 vaccination during 2020–2024. medRxiv. 2024:24316673. https://doi.org/10.1101/2024.1....
3.
Rangelova V, Raycheva R, Sariyan S, Kevorkyan A. Reporting adverse events of COVID-19 vaccines: The case of Bulgaria. PLoS One. 2022;17(6):e0269727. https://doi.org/10.1371/journa....
4.
Niesen MJM, Pawlowski C, O'Horo JC, et al. Surveillance of safety of 3 doses of COVID-19 mRNA vaccination using electronic health records. JAMA Netw Open. 2022;5(4):e227038. https://doi.org/10.1001/jamane....
5.
Bonanni P, Steffen R, Schelling J, et al. Vaccine co-administration in adults: An effective way to improve vaccination coverage. Hum Vaccin Immunother. 2023;19(1):2195786. https://doi.org/10.1080/216455....
6.
Mo Y, Zeng J, Xiao C, et al. Effectiveness and safety of pneumococcal vaccines used alone or combined with influenza vaccination in dialysis patients: A systematic review and meta-analysis. Vaccine. 2020;38(47):7422–7432. https://doi.org/10.1016/j.vacc....
7.
UNICEF. UNICEF Immunization Roadmap To 2030: The priorities for immunization through the end of this decade. 2024. https://www.unicef.org/documen.... Accessed: January 5, 2025.
8.
Vaccine Adverse Events Reporting System. https://vaers.hhs.gov/index.ht.... Accessed: January 5, 2025.
9.
Centers for Disease Control and Prevention. https://www.cdc.gov/about/cdc/.... Accessed: January 5, 2025.
12.
World Health Organization. Global COVID-19 Vaccination Strategy in a Changing World: July 2022 update. 2022. https://www.who.int/publicatio.... Accessed: January 5, 2025.
13.
The White House. National COVID-19 Preparedness Plan. 2024. https://www.whitehouse.gov/cov.... Accessed: January 5, 2025.
14.
Food and Drug Administration. Emergency Use Authorization. https://www.fda.gov/emergency-.... Accessed: January 5, 2025.
15.
Centers for Disease Control and Prevention. Product Info by U.S. Vaccine. 2024. https://www.cdc.gov/vaccines/c.... Accessed: January 5, 2025.
16.
Wong MK, Brooks DJ, Ikejezie J, et al. COVID-19 mortality and progress toward vaccinating older adults – World Health Organization, Worldwide, 2020–2022. MMWR Morb Mortal Wkly Rep. 2023;72(5):113–118. http://dx.doi.org/10.15585/mmw....
17.
Reuters. Bulgaria: World coronavirus tracker and maps. 2022. https://www.reuters.com/graphi.... Accessed: January 5, 2025.
18.
World Health Organization. Bulgaria: Country Health Profile 2023. 2023. https://eurohealthobservatory..... Accessed: January 5, 2025.
19.
National COVID-19 vaccination plan. Epicentro. 2021. https://www.epicentro.iss.it/e...: January 5, 2025.
20.
Italy: World coronavirus tracker and maps. Reuters. 2022. https://www.reuters.com/graphi.... Accessed: January 5, 2025.
22.
US Coronavirus vaccine tracker. 2024. https://usafacts.org/visualiza.... Accessed: January 5, 2025.
23.
European Centre for Disease Prevention and Control (ECDC). 2023. COVID-19 Vaccine Tracker. https://vaccinetracker.ecdc.eu.... Accessed: January 5, 2025.
24.
Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA. ECDC. 2023. https://www.ecdc.europa.eu/en/.... Accessed: January 5, 2025.
25.
Kozlovskyi S, Bilenko D, Kuzheliev M, Ivanyuta N, Butenko V, Lavrov R. Comparison and Assessment of Factors Affecting the COVID-19 Vaccination in European Countries. Probl Ekorozw. 2021;16:26–33. https://doi.org/10.35784/pe.20....
26.
Toshkov D. What accounts for the variation in COVID-19 vaccine hesitancy in Eastern, Southern and Western Europe? Vaccine. 2023;41(20):3178–3188. https://doi.org/10.1016/j.vacc....
27.
Zastawna B, Milewska A, Załuska R, Kozłowski R, Zastawna M, Marczak M. Analysis of parents' attitudes and knowledge toward immunization and how these factors influence their decisions to vaccinate their children against Human Papilloma Virus (HPV). Medicina. 2023;59(10):1755. https://doi.org/10.3390/medici....
28.
Kutasi K, Koltai J, Szabó-Morvai Á, Röst G, Karsai M, Biró P, Lengyel B. Understanding hesitancy with revealed preferences across COVID-19 vaccine types. Sci Rep. 2022;12:13293. https://doi.org/10.1038/s41598....
29.
Bussink-Voorend D, Hautvast JLA, Vandeberg L, Visser O, Hulsher MEJL. A systematic literature review to clarify the concept of vaccine hesitancy. Nat Hum Behav. 2022;6:1634–1648. https://doi.org/10.1038/s41562....
30.
Khankeh H, Pourebrahimi M, Hosseinabadi-Farahani M, et al. Comparison of vaccine hesitancy during the low and high points of COVID-19 in a population under international sanctions: A longitudinal mixed-methods study in Iran. Front Public Health. 2023;10:958899. https://doi.org/10.3389/fpubh.....
31.
Aidalina M, Khalsom S. COVID-19 vaccination: A systematic review of vaccination strategies based on economic evaluation studies. Med J Malaysia. 2023;78(3):411–420.
32.
Couderc AL, Ninove L, Nouguerède E, et al. Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancer. J Geriatr Oncol. 2022;13(6):850–855. https://doi.org/10.1016/j.jgo.....
33.
Gil-Díaz A, Gil-Hernández A, Lozano-Jiménez AI, Benítez-Peña J, Conde-Martel A. Safety of COVID-19 vaccination in patients with previous cerebral venous sinus thrombosis. Thromb Res. 2021;209:84–85. https://doi.org/10.1016/j.thro....
34.
Bellomo RG, Gallenga CE, Caraffa A, Tetè G, Ronconi G, Conti P. Anaphylaxis is a rare reaction in COVID-19 vaccination. J Biol Regul Homeost Agents. 2021;35(3):839–842. https://doi.org/10.23812/bello....
35.
Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci. 2022;43:3–40. https://doi.org/10.1007/s10072....
36.
Zavala-Jonguitud LF, Pérez-García CC. Delirium triggered by COVID-19 vaccine in an elderly patient. Geriatr Gerontol Int. 2021;21(6):540. https://doi.org/10.1111/ggi.14....
37.
Vaccines and immunization. WHO. 2020. https://www.who.int/health-top.... Accessed: January 5, 2025.
38.
Immunization dashboard: Global reported cases of vaccine-preventable diseases (VPDs). WHO. 2023. https://immunizationdata.who.i.... Accessed: January 5, 2025.
39.
Misinformation Management Guide: Guidance for addressing a global infodemic and fostering demand for immunization. WHO. 2020. https://vaccinemisinformation..... Accessed: January 5, 2025.
40.
Durand J, Dogné J, Cohet C, Browne K, Gordillo-Marañón M, Piccolo L, et al. Safety monitoring of COVID-19 vaccines: Perspective from the European Medicines Agency. Clin Pharmacol Ther. 2023;113(6):1223–1234. https://doi.org/10.1002/cpt.28....
41.
De Camargos SM, Oliveira MLS, Luvisaro BMO, Silva TPRD, Souza JFA, Vimieiro AM, et al. Adverse event following immunization or vaccination in children in Minas Gerais: 2015 to 2020. Rev Bras Epidemiol. 2023;26:e230056. https://doi.org/10.1590/1980-5....
42.
Miller CK, Mendoza JC, Coop CA. Anaphylaxis to MMR vaccine mediated by IgE sensitivity to gelatin. Mil Med. 2020;185(9–10):e1869–e1871. https://doi.org/10.1093/milmed....
43.
Winkelmann A, Metze C, Zettl UK, Loebermann M. Side effects following vaccination in multiple sclerosis: A prospective, multi-centre cohort study. Sci Rep. 2023;13:14480. https://doi.org/10.1038/s41598....
44.
Meleis MM, Hahn SB, Carraro MN, Deutsch AB. Extensive longitudinal acute transverse myelitis complicated by pulseless ventricular tachycardia and recent shingles vaccination. Am J Emerg Med. 2023;68:213.e1–213.e3. https://doi.org/10.1016/j.ajem....
45.
Lataster R. Scientific views around mRNA based covid vaccines are changing, but to what end?. Pol Ann Med. 2024;31(2):158–161. https://doi.org/10.29089/paom/....
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
